key: cord-0955579-xql20h1j authors: Mahshid, Sahar Sadat; Flynn, Sarah Elizabeth; Mahshid, Sara title: The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2 date: 2020-12-17 journal: Biosens Bioelectron DOI: 10.1016/j.bios.2020.112905 sha: b1506e1a32cf57bf9aa737530d2bdb2bd581f5b0 doc_id: 955579 cord_uid: xql20h1j Electrochemical biosensors combine the selectivity of electrochemical signal transducers with the specificity of biomolecular recognition strategies. Although they have been broadly studied in different areas of diagnostics, they are not yet fully commercialized. During the COVID-19 pandemic, electrochemical platforms have shown the potential to address significant limitations of conventional diagnostic platforms, including accuracy, affordability, and portability. The advantages of electrochemical platforms make them a strong candidate for rapid point-of-care detection of SARS-CoV-2 infection by targeting not only viral RNA but antigens and antibodies. Herein, we reviewed advancements in electrochemical biosensing platforms towards the detection of SARS-CoV-2 through studying similar viruses. J o u r n a l P r e -p r o o f finger-prick blood, nasopharyngeal, and saliva samples, for target analytes. The platforms 151 possess (1) a readout device (2) a biosensing chip with sample delivery system and electronic 152 leads to transfer the response of the electrodes to the readout device, (3) electrodes with the 153 corresponding recognition elements of complementary oligonucleotides, antibodies, antigens to 154 detect the target oligonucleotides, antigens, and antibodies, respectively, with a quantifiable 155 current response proportional to the analyte concentration. 156 The device was designed with one inlet and three outlets, each outlet channel containing a sensor 294 region with different virus-specific capture-antibodies. ZnO nanorods were grown in the sensor 295 regions of the PDMS-microfluidic device hanging over the electrodes and were electrostatically 296 immobilized with capture antibodies. To electrochemically detect the three virus subtypes, they 297 used a modified sandwich ELISA assay with the detection antibodies conjugated to horseradish 298 peroxidase (HRP). When the detection antibodies bind to target viruses on the sensor regions, the 299 applied potential causes HRP to generate electrons through the oxidation of 3,3',5,5'-300 tetramethylbenzidine in solution (Scheme 4-B) . The resultant current was recorded by the 301 amperometric measurements with a limit of detection of 1 pg/mL for all analytes ( Table 2 , 302 is not affected by the interference of the control antibody, resulting in a limit of detection of 2.1 357 pg/mL ( Table 2 , and Scheme 4-E''). The applicability of this biosensor was verified using 358 dilutions of vaccinated hen sera in the concentration range of 7×10 3 to 7×10 7 , which showed 359 almost 10 4 times more sensitivity compared to ELISA. The same research group later developed H1N1. They used the same His-tagged hemagglutinin (His 6 -H5 HA) as the recognition element, 362 which was covalently attached to a 4-mercaptobutanol-modified gold electrode. The recognition 363 element was immobilized in an oriented fashion using dipyrromethene (DPM)-Cu (II) complex 364 as a histidine tag surface-receptor. The DPM-Cu (II) complex also served as the electroactive 365 marker, relying on the Cu(II)/Cu(I) redox current to generate a response measured through 366 square wave voltammetry ( Table 2) . This sensor was assessed using vaccinated mice sera 367 samples at various dilutions. Antibodies were detected at sera dilutions from 1×10 8 to 1×10 9 368 fold, which is approximately 10 7 times more sensitive than standard ELISA tests (Mikuła et al. When subjected to an electrical potential, this complex becomes excited and emits light (Sano 387 and Tatsumi 1996) . Compared with ELISA and chemiluminescence assays, the Roche platform 388 shows similar and promising specificity, albeit with a slightly lower sensitivity (Hörber et al. Throughout the COVID-19 pandemic, the role of testing and the degree of implementation 402 has been widely debated. Early and widespread testing for SARS-CoV-2 has proven to reduce 403 mortality rates and improve contact tracing. However, the value of testing is directly linked to 404 the availability and accuracy of diagnostic tests. As concerns grow regarding the application of 405 RT-PCR and ELISA-based testing, particularly the complexity of the assays during inventory 406 shortages, the development of easy-to-use alternative platforms is encouraged with specific 407 attention paid to sensitivity and simplicity. Genosensor on gold films with 455 enzymatic electrochemical detection of a SARS virus sequence Laboratory diagnosis of SARS-CoV-2: available approaches and 458 limitations Novel graphene-based biosensor for early detection 461 of Zika virus infection Journal of Infection and Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR Detection of 2019 novel coronavirus (2019-495 nCoV) by real-time RT-PCR Laboratory testing methods for novel severe 499 acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Electrochemical Biosensors in Point-of-Care Devices: Recent Advances and 503 505 biosensors Hybridization biosensor using di(2,2′-559 bipyridine)osmium (III) as electrochemical indicator for detection of polymerase chain reaction 560 product of hepatitis B virus DNA A highly sensitive molecular detection platform for robust and facile diagnosis of Middle East respiratory syndrome (MERS) corona virus Comparing the Properties 566 of Electrochemical-Based DNA Sensors Employing Different Redox Tags Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA Biosensors for plant pathogen 572 detection Electrochemical detection of nucleic acids, proteins, small molecules and cells using a DNA-602 nanostructure-based universal biosensing platform Functional Nucleic Acid Sensors Development of a novel electrochemical immuno-biosensor 606 for circulating biomarkers of the inner ear Electrochemical Steric Hindrance Assay for One-Step Detection of HIV Antibodies Electrochemical genosensor based on disc and screen printed gold electrodes 612 for detection of specific DNA and RNA sequences derived from Avian Influenza Virus H5N1 Genosensor for SARS 615 virus detection based on gold nanostructured screen-printed carbon electrodes -617 5), 379-385. challenges and pitfalls Highly 625 sensitive electrochemical biosensor based on redox -active monolayer for detection of anti-626 hemagglutinin antibodies against swine-origin influenza virus H1N1 in sera of vaccinated mice The French response to COVID-19: intrinsic difficulties at the interface of 629 science, public health, and policy The impact of biosensing in a pandemic outbreak: 631 COVID-19 A DNA mimic with 633 a peptide backbone Laboratory testing for coronavirus disease 2019 (COVID-19) in 635 suspected human cases: interim guidance Point-of-care serological assays for delayed SARS CoV-2 case identification among health-care workers in the UK: a prospective multicentre 639 cohort study Electrochemical genosensor design: immobilisation 641 of oligonucleotides onto transducer surfaces and detection methods. Biosensors and Nanosystems for Viral Infection Diagnostics SARS-CoV-2, SARS-CoV, and 649 MERS-COV: A comparative overview Clinical Performance of the Roche SARS-CoV-2 Serologic Assay Trends and innovations in biosensors for COVID-19 mass testing The GenMark ePlex®: another weapon in the syndromic 658 arsenal for infection diagnosis COVID-19: A Risk Assessment Perspective Graphene Oxide-based Electrochemical Immunosensor Integrated with a Microfluidic Platform A sensitive label-free impedimetric DNA biosensor based on silsesquioxane-673 functionalized gold nanoparticles for Zika Virus detection Electrochemical biosensors for influenza virus a detection: The 676 potential of adaptation of these devices to POC systems Electrochemical biosensors: 679 recommended definitions and classification Biosensors: sense and sensibility Diagnosing COVID-19: the disease and tools 684 for detection Comparing the analytical performance of three SARS-CoV-2 687 molecular diagnostic assays Handbook of Immunoassay Schmidt-Mutter CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Diagnostic 694 microbiology and infectious disease CoV-2 detection, viral load and infectivity over the course of an infection A new coronavirus associated with human respiratory disease 702 in China A reagentless signal-on architecture 704 for electronic, aptamer-based sensors via target-induced strand displacement Chest CT for typical 2019-707 nCoV pneumonia: relationship to negative RT-PCR testing. Radiology, 200343. for Point-of-Care applications Ultrasensitive 717 electrochemical detection of avian influenza A (H7N9) virus DNA based on isothermal 718 exponential amplification coupled with hybridization chain reaction of DNAzyme nanowires DNA hydrolysis and voltammetric 721 determination of guanine and adenine using different electrodes Molecular and serological investigation of 2019-nCoV infected patients: 725 implication of multiple shedding routes Clinical evaluation of three 727 sample-to-answer platforms for detection of SARS-CoV-2 Aptamer-based biosensors for biomedical 730 diagnostics We dedicate our work to the front-line workers and healthcare providers whose roles can be 449 assisted through more efficient methods for point-of-care diagnostics during the pandemic. The